| 股票代码 | 股票名称 | 持有份额(万股) | 仓位比例 | 涨跌 | 贡献增长率 |
| 600276 | 恒瑞医药 | 0.0000 | 9.02% | 2.44% | 0.2201% |
| 688266 | 泽璟制药-U | 0.0000 | 8.24% | -1.66% | -0.1368% |
| 688428 | 诺诚健华 | 0.0000 | 7.56% | -2.88% | -0.2177% |
| 688192 | 迪哲医药-U | 0.0000 | 7.48% | -1.70% | -0.1272% |
| 688382 | 益方生物-U | 0.0000 | 6.15% | -0.58% | -0.0357% |
| 688331 | 荣昌生物 | 0.0000 | 5.92% | -2.17% | -0.1285% |
| 002755 | 奥赛康 | 0.0000 | 5.69% | -2.72% | -0.1548% |
| 688180 | 君实生物-U | 0.0000 | 5.53% | -1.22% | -0.0675% |
| 01801 | 信达生物 | 0.0000 | 4.84% | -0.40% | -0.0194% |
| 002714 | 牧原股份 | 0.0000 | 3.33% | -2.79% | -0.0929% |
| 重仓股仓位合计 | 重仓股贡献增长率 | 总持股仓位 | 修正增长率 | ||
| 63.76% | -0.7604% | 88.97% | |||
| 日期 | 实际增长率 | 预估增长率 |
| 2026-10-14 | -2.13% | -1.71% |
| 2026-10-13 | -1.12% | -0.66% |
| 2026-10-12 | -1.89% | -2.09% |
| 2026-10-09 | 0.78% | 0.60% |
| 2026-10-08 | -5.24% | -3.42% |
| 2026-09-30 | 2.52% | 2.50% |
| 2026-09-29 | 1.10% | 0.65% |
| 2026-09-28 | -1.36% | -1.70% |
| 基金名称 | 单位净值 | 日增长率 |
| 国联鑫思路混合A | 1.8089 | -0.1290% |
| 国联鑫思路混合C | 1.7525 | -0.1290% |
| 国联央视财经50ETF | 1.5748 | -0.3200% |
| 国联国企改革混合A | 1.8535 | -0.3513% |
| 国联景泓一年持有混合A | 1.0180 | -0.4680% |
| 国联景泓一年持有混合C | 1.0077 | -0.4680% |
| 国联优势产业混合A | 1.1939 | -0.5491% |
| 国联优势产业混合C | 1.1658 | -0.5491% |
| 基金名称 | 单位净值 | 日增长率 |
| 国泰聚鑫量化选股混合发起A | 1.8794 | 0.6913% |
| 国泰聚鑫量化选股混合发起C | 1.8752 | 0.6913% |
| 华商科创创业精选混合A | 1.7212 | 0.6372% |
| 华商科创创业精选混合C | 1.7150 | 0.6372% |
| 泰信消费精选混合发起式A | 0.7780 | 0.4797% |
| 泰信消费精选混合发起式C | 0.7769 | 0.4797% |
| 长城医疗保健混合C | 2.5516 | 0.3227% |
| 长城医疗保健混合A | 2.6200 | 0.3031% |